Showing the latest 10 filings. Sign in to filter or browse the full history.
Showing 10 of 36 filings.
13 Aug 20261 filing
Financial results approved
- Approved standalone unaudited results for quarter ended 30 June 2026; Limited Review Report by statutory auditor enclosed.
12 Aug 20261 filing
EGM details
- Date: 10 August 2026; 37 attendees (4 promoters, 33 public).
- Resolutions: 2 ordinary resolutions on warrants and auditor appointment.
Resolutions and outcomes
- Resolution 1: Ratification of convertible warrants on preferential basis; Ordinary; 99.88% in favour.
- Resolution 2: Appointment of Statutory Auditor to fill casual vacancy; Ordinary; 99.88% in favour.
Promoter interest
- Promoter group not interested in either resolution.
Voting results
- Postal ballot: 50 members cast; 1,064,764 votes; 99.88% in favour; 1,200 against.
10 Aug 20262 filings
Resolutions
- Ordinary: Ratification of convertible warrants allotment on a preferential basis.
- Ordinary: Appointment of Statutory Auditor to fill casual vacancy.
Voting Outcome
- Results pending; e-voting results to be informed to stock exchanges.
- Auditor appointment results pending.
Governance/Impact
- Potential dilution on warrant conversion not specified.
- Auditor appointment to fill casual vacancy; affects governance and board oversight.
Meeting Details
- Board meeting scheduled on 13 August 2026; time and venue not disclosed.
Key Agenda Items
- Consider and approve unaudited results for quarter ended 30 June 2026.
Other Notes
- Trading window closed from 1 July 2026 to 48 hours after results declaration.
- Notice of board meeting to be available on company website and BSE.
16 Jul 20261 filing
Warrant issue
- Ordinary resolution to ratify the preferential allotment of 2,13,00,000 Convertible Warrants.
- Issue price ₹10.35 per warrant; total ₹22,04,55,000.
- Upfront receipt 25%; balance payable on conversion within 18 months.
- Warrants convert to equity shares of ₹10; pari-passu ranking; lock-in applies.
- Annexure A lists allottees; all are non-promoter.
- Board authorized to issue letters, file returns, and list on exchanges.
Auditor appointment
- Ordinary resolution to appoint statutory auditors for casual vacancy.
- Appointee: M/s CGH & ASSOCIATES (Firm No. 025528C).
- Term from 27 February 2026 to conclusion of 2025-26 AGM.
- Remuneration fixed at ₹2,25,000 per annum; other services may be availed.
- Board and Company Secretary authorized to finalize terms and filings.
- No director or KMP other than shareholding has interest.
15 Jul 20261 filing
EGM convening and related approvals
- EGM scheduled for Aug 10, 2026 at 4:00 PM to approve warrants and statutory auditor appointment.
- Ratification of convertible warrants on a preferential basis.
- Appointment of Statutory Auditor to fill casual vacancy.
- Scrutinizer appointed for EGM: CS Chandan Jha (M.No. A62350).
- Notice of EGM to be submitted to stock exchange and published in English and Hindi newspapers.
14 Jul 20261 filing
Dematerialisation processing & registry updates
- Requests processed; confirmations (accepted/rejected) sent to Depositories within 15 days of receipt.
- Certificates for dematerialisation mutilated and cancelled after verification; Depository name substituted in Register of Members.
- Records updated with Depository and Stock Exchanges within 15 days.
- Register of Members updated accordingly.
12 Jul 20261 filing
Meeting Details
- Board meeting scheduled for Wednesday, 15 July 2026; time and venue not disclosed.
Key Agenda Items
- Proposal to convene an Extraordinary General Meeting (EGM) of shareholders and draft EGM notice.
- Any other matter with the permission of the Chair.
Other Notes
6 Jul 20262 filings
Warrants allotment
- Board approves allotment of 2,13,00,000 fully convertible warrants on a preferential basis.
- Issue price per warrant is Rs 10.35.
- Warrant subscription price is Rs 2.58.
- Warrant exercise price is Rs 7.77.
- Total issue size Rs 22.04 crore.
- Warrants exercisable into one equity share of Re 10 each.
- Tenure: warrants exercisable within 18 months from allotment.
- Upfront payment: 25% of total consideration; balance 75% on exercise.
- Allottees: 29 non-promoter/public investors; names in Annexure A.
- Post-issuance holdings show investors up to 7.51% stake.